Showing results (41-50 of 59) with videos related to
Sort By:
Pageof 6
Iscience|August 2, 2019
Small Molecule Binding to Alzheimer Risk Factor CD33 Promotes Aβ PhagocytosisLuke A Miles, Stefan J Hermans, Gabriela A N Crespi, et al.Cell Death & Disease|April 10, 2024
Combination of bazedoxifene with chemotherapy and SMAC-mimetics for the treatment of colorectal cancerRhynelle S Dmello, Michelle Palmieri, Pathum S Thilakasiri, et al.Cancer Medicine|November 6, 2024
Combined inhibition of histone methyltransferases EZH2 and DOT1L is an effective therapy for neuroblastomaJanith A Seneviratne, Daenikka Ravindrarajah, Daniel R Carter, et al.The Journal of Experimental Medicine|February 4, 2015
Phosphorothioate backbone modifications of nucleotide-based drugs are potent platelet activatorsUlrike Flierl, Tracy L Nero, Bock Lim, et al.NPJ Biofilms and Microbiomes|November 20, 2025
Chemical inhibition of MrkH-dependent activation of type 3 fimbriae synthesis and biofilm formation by Klebsiella pneumoniaeJonathan J Wilksch, Jason W H Tan, Tracy L Nero, et al.EMBO Molecular Medicine|March 20, 2019
Repurposing the selective estrogen receptor modulator bazedoxifene to suppress gastrointestinal cancer growthPathum Thilakasiri, Jennifer Huynh, Ashleigh R Poh, et al.Nature Communications|January 28, 2018
A dual role for the N-terminal domain of the IL-3 receptor in cell signallingSophie E Broughton, Timothy R Hercus, Tracy L Nero, et al.Immunological Reviews|January 3, 2025
The β Common Cytokine Receptor Family Reveals New Functional Paradigms From Structural ComplexitiesWinnie L Kan, Claire M Weekley, Tracy L Nero, et al.Cell Reports|July 22, 2014
Dual mechanism of interleukin-3 receptor blockade by an anti-cancer antibodySophie E Broughton, Timothy R Hercus, Matthew P Hardy, et al.Nature Communications|January 24, 2017
Transitional changes in the CRP structure lead to the exposure of proinflammatory binding sitesDavid Braig, Tracy L Nero, Hans-Georg Koch, et al.Pageof 6